argenx SE Total Liabilities 2011-2026 | ARGX

Annual Total Liabilities argenx SE

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
704 M	445 M	321 M	316 M	605 M	430 M	-	-	42.4 M	8.68 M	8.43 M	3.31 M	4.75 M	3.12 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
704 M	3.12 M	241 M

Quarterly Total Liabilities argenx SE

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	316 M	-	261 M	-	605 M	-	-	-	430 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
605 M	261 M	403 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Altimmune ALT	55 M	$ 3.45	3.29 %	$ 304 M	USA
Amgen AMGN	50 B	$ 351.92	1.18 %	$ 189 B	USA
Amphastar Pharmaceuticals AMPH	840 M	$ 19.55	0.26 %	$ 914 M	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Autolus Therapeutics plc AUTL	355 M	$ 1.4	1.82 %	$ 357 M	Britain
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	1.47 B	$ 218.41	-1.57 %	$ 5 B	Danmark
Aytu BioScience AYTU	93.3 M	$ 2.61	-	$ 16.4 M	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Benitec Biopharma BNTC	2.3 M	$ 11.01	0.27 %	$ 453 M	USA
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	7.8 M	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Compugen Ltd. CGEN	18.5 M	$ 2.08	-0.48 %	$ 194 M	Israel
Avenue Therapeutics ATXI	816 K	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Coherus BioSciences CHRS	197 M	$ 1.59	4.28 %	$ 186 M	USA
CollPlant Biotechnologies Ltd. CLGN	5.24 M	$ 0.6	-1.9 %	$ 6.87 M	Israel
Cellectis S.A. CLLS	249 M	$ 3.37	0.75 %	$ 116 M	France
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	39.6 M	$ 12.91	1.33 %	$ 778 M	USA
Atreca BCEL	76.6 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	137 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	3.83 B	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	15.7 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	68.8 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	140 M	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
CorMedix CRMD	421 M	$ 6.32	1.12 %	$ 455 K	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	752 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Denali Therapeutics DNLI	144 M	$ 20.96	3.92 %	$ 3.45 B	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	38.4 M	$ 4.26	0.35 %	$ 707 M	Canada
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	7.27 M	-	1.93 %	$ 17.4 M	USA